NCT00015301CompletedPhase 4
Methylphenidate Raclopride PET Test
Conditions
Drugs
Trial Snapshot
- Phase
- Phase 4
- Status
- Completed
- Locations
- 2
- Primary Endpoint
- Dopamine receptor availability
Study Overview
Brief Summary
The purpose of this study is to evaluate PET methodology to study in vivo synaptic dopamine release.
Detailed Description
The objective of this study is to evaluate PET methodology to study in vivo synaptic dopamine release.
Study Design
- Study Type
- Interventional
- Primary Purpose
- Diagnostic
- Masking
- Double
Eligibility Criteria
- Ages
- 18 Years to 75 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Healthy normals
Exclusion Criteria
- •History of head trauma or loss of consciousness. Significant medical history. History of seizures.
Outcomes
Primary Outcomes
Dopamine receptor availability
Secondary Outcomes
No secondary outcomes reported
Investigators
Study Sites (2)
Loading locations...
Similar Trials
Completed
Not Applicable
Dopamine Function in Developmental StutteringDevelopmental StutteringNCT00024960National Institute on Deafness and Other Communication Disorders (NIDCD)12
Completed
Phase 3
A PET Study Examining Pharmacokinetics and Dopamine Transporter Receptor Occupancy Of Two Long-Acting Formulations of Methylphenidate in AdultsHealthy VolunteersNCT00301639Massachusetts General Hospital40
Completed
Not Applicable
Test-retest Reproducibility of [11C]PHNO PET Using the Constant Infusion ParadigmNicotine DependenceHealthyNCT01699607Yale University10
Completed
Phase 1
PET Study Examining the Dopaminergic Activity of Armodafinil in AdultsHealthyNCT00592943Massachusetts General Hospital12
Terminated
Not Applicable
PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [11C]PBR28 in HIV-Seropositive Patients With (MCMD)HIV-DementiaHIV-Associated Cognitive Motor ComplexAIDS EncephalopathyAIDS Dementia ComplexAIDS-Related Dementia ComplexHealthyHIV InfectionsNCT00459693National Institute of Mental Health (NIMH)40